Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells
about
The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculasVascular Effects of Dietary Advanced Glycation End ProductsAlbumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cellsAdvanced glycation: an important pathological event in diabetic and age related ocular diseaseThe effect of an AGE-rich dietary extract on the activation of NF-κB depends on the cell model used.AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Therapeutic potential of endothelin receptor antagonists in diabetes.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.The maillard reaction in eye diseases.The AGE-receptor in the pathogenesis of diabetic complications.Diabetic complications and dysregulated innate immunity.Endothelins in chronic diabetic complications.Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes.Cellular signaling and potential new treatment targets in diabetic retinopathy.Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic RatsVascular effects of advanced glycation endproducts: Clinical effects and molecular mechanismsDietary hyperglycemia, glycemic index and metabolic retinal diseases.Galectin-3: an emerging all-out player in metabolic disorders and their complications.Mechanisms of distal axonal degeneration in peripheral neuropathies.Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epitheliumNeurodegenerative diseases of the retina and potential for protection and recoveryCellular carbonyl stress enhances the expression of plasminogen activator inhibitor-1 in rat white adipocytes via reactive oxygen species-dependent pathway.Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations.Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction.
P2860
Q24602544-F1718B81-D489-4FD4-BB9F-02B194BBFE45Q28081090-2D2899ED-9893-45DE-9DF7-3C42471829E9Q28362386-17BCD6BE-DC41-4278-9FB0-AB1864ADA5CFQ28365776-B2B52EDB-A003-4F4D-BB78-E08D45F1115BQ30317876-D94CB539-E2A0-4F41-9CA9-4A52394ADB84Q33727690-0192B4B5-228A-4DC1-B379-EC4F7D21A44BQ34090982-F05714F7-CC1B-43D6-A424-313E72464A45Q34103169-BF2279AB-005C-4BB5-B6AA-374566F13835Q34436018-C02C7583-E96A-4FD4-A890-2FB7DC667399Q34470639-AE3D243E-A523-40BB-9DA8-528594D4B30FQ35087841-61100562-AFC3-4A5C-AAA4-F5F00186FA8AQ35168430-C8E17937-79C9-49DF-8746-C3984E2278B8Q35553234-71094FD7-27E9-4A7E-9622-8305E51AC2D4Q35842591-74B756AB-8CB2-4515-AE5F-8D25B13981CCQ37089750-2867EAE8-DF3C-455E-8C8B-4C9EE4790862Q37202605-C33E859A-3853-485D-88FB-6439B5AE0CA3Q37636453-E6BAE98A-99A3-42E7-9248-50311E8D48ABQ37733102-D7C7407B-0259-4DAB-897F-4EFE3577C8D7Q38258947-BC224F71-532A-4982-8A40-0C8AB6693E45Q38330759-D08E5B4E-56F1-41F1-84DE-746FCCB84A00Q39700115-B335AAD3-D2BE-48DB-9918-C52D48480E7FQ40477757-2CECFB89-4974-458A-BAE2-BEA61466FF5DQ41997847-29B664D5-925A-4413-8739-4C38B76B53C8Q44650505-3AE463EE-13B3-4E04-B9A4-472E11F3D6E4Q45151232-B4491FBF-084F-4754-9047-B5606786A48FQ48580864-AE86309B-8C09-4C5D-9D3B-66DAA564BF12Q53510307-7A2D9853-DDD6-41D9-8EE0-BCE3022D0058
P2860
Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of the advanc ...... man vascular endothelial cells
@ast
Characterization of the advanc ...... man vascular endothelial cells
@en
Characterization of the advanc ...... man vascular endothelial cells
@nl
type
label
Characterization of the advanc ...... man vascular endothelial cells
@ast
Characterization of the advanc ...... man vascular endothelial cells
@en
Characterization of the advanc ...... man vascular endothelial cells
@nl
prefLabel
Characterization of the advanc ...... man vascular endothelial cells
@ast
Characterization of the advanc ...... man vascular endothelial cells
@en
Characterization of the advanc ...... man vascular endothelial cells
@nl
P3181
P356
P1476
Characterization of the advanc ...... man vascular endothelial cells
@en
P304
P3181
P356
10.1006/BBRC.1999.0291
P407
P50
P577
1999-03-01T00:00:00Z